Nasdaq: GTBP

Press Releases

Press Releases

GT Biopharma to Participate in the 10th Anniversary of the Innate Killer Summit

March 4, 2025

GT Biopharma Announces Exercise of Warrants

February 25, 2025

GT Biopharma Announces Request for Withdrawal of Form S-1 Registration Statement

February 25, 2025

GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-3650, Second-Generation TriKE for the Treatment of Hematologic Malignancies

January 27, 2025